For example, one patient with SLE overlapping with BP achieved significant clinical remission and steroid sparing after RTX-BLM sequential treatment, suggesting that a combination therapy of anti-CD20 and anti-BAFF mAbs might maintain longer B cell depletion and clinical remission (172). This evidence concerns the gene TNFSF13B and systemic lupus erythematosus.